Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

896.53 +33.67 (+3.90%)
Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
'Our GPUs Are Everywhere’ According to CEO Jensen Huang as Nvidia Doubles Down on AI, Quantum, and 6G
Nvidia stock continues to surge higher as the AI chipmaker widens its moat significantly. 
Via Barchart.com
Topics Artificial Intelligence
Eli Lilly (LLY) Stock Trades Up, Here Is Why
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the morning session after the company reported a "beat and raise" quarter. 
Via StockStory
Topics Artificial Intelligence Economy Government
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera. 
Via Investor's Business Daily
Topics Economy Government
Earnings Scheduled For October 30, 2025
 
Via Benzinga
Earnings Outlook For Eli Lilly
 
Via Benzinga
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome... 
Via Benzinga
Topics Economy
Nvidia's $5 Trillion Milestone Turns These AI ETFs Into Hot Trades
Nvidia's $5 trillion valuation record is igniting momentum across semiconductor and AI-themed ETFs as investors chase the next leg of the chip supercycle. 
Via Benzinga
Topics Artificial Intelligence ETFs
Tech Titans Tumble, Alphabet Soars as Market Opens Mixed on AI Spending Jitters
The U.S. stock market opened with a palpable sense of divergence on October 30, 2025, as investors grappled with a mixed bag of quarterly earnings and forward-looking statements from the nation's... 
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
Eli Lilly (LLY) Q3 2025 Earnings Call Transcript
Eli Lilly (LLY) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Eli Lilly CEO Dave Ricks Reportedly Says Company Eyeing Pain Relief Market With Weight Loss Drug Retatrutide
CEO Dave Ricks told CNBC that the first study the company plans to read out for Retatrutide will be on knee pain. 
Via Stocktwits
Navigating the Currents: Dow Jones Shows Resilience Amidst Fed's Caution and Geopolitical Shifts
The Dow Jones Industrial Average (DJIA) finds itself navigating a complex economic landscape as of October 30, 2025, exhibiting resilience despite a barrage of mixed signals from central bank policies,... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast
Eli Lilly reported Q3 revenue of $17.6 billion, beating estimates and raising 2025 guidance as Mounjaro and Zepbound sales surged. 
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
 
Via Benzinga
Eli Lilly Delivers Strong Q3 Performance, Raises Earnings Outlook
Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its full-year guidance. 
Via Talk Markets
These S&P500 stocks are moving in today's pre-market session
Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session. 
Via Chartmill
Eli Lilly & Co (NYSE:LLY) Q3 2025 Earnings Beat Estimates, Fueling Pre-Market Rally
Eli Lilly's Q3 2025 results crushed estimates, driven by high demand for Mounjaro and Zepbound. The company raised its full-year outlook, sparking a stock rally. 
Via Chartmill
Topics Earnings
Eli Lilly Blows Past Expectations On The Back Of Mounjaro, Zepbound
Shares jumped early Thursday after the drugmaker easily topped third-quarter forecasts. 
Via Investor's Business Daily
Eli Lilly (NYSE:LLY) Delivers Strong Q3 Numbers, Stock Soars
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue... 
Via StockStory
Understanding Market Records: Is This Sustainable Growth?
The global stock market is currently navigating an unprecedented era of record-breaking growth in late October 2025, a phenomenon largely orchestrated by the remarkable performance and pervasive... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
Nvidia Shatters Records: AI Powerhouse Hits $5 Trillion Market Cap, Reshaping Global Economy
In a historic moment for the technology and financial worlds, Nvidia Corporation (NASDAQ: NVDA) officially achieved an unprecedented $5 trillion market capitalization on Wednesday, October 29, 2025.... 
Via TokenRing AI
Topics Artificial Intelligence Economy Emissions
Eli Lilly Advances AI And Access: Supercomputer With NVIDIA, Zepbound Via Walmart
Eli Lilly partners with NVIDIA to build a powerful AI supercomputer and teams up with Walmart to expand affordable Zepbound access nationwide. 
Via Benzinga
Topics Artificial Intelligence
Nvidia Shatters Records with $5 Trillion Market Cap, Cementing AI Revolution Leadership
Santa Clara, CA – October 29, 2025 – In a historic moment for the technology sector, Nvidia (NASDAQ: NVDA) has officially achieved an unprecedented $5 trillion market capitalization, becoming the first... 
Via MarketMinute
Topics Artificial Intelligence Economy
Nvidia's 2 Surprises; NVDA Soars On Trump-Fueled Hopes of China Blackwell Sales; Fed In Focus
Two Nvidia Shockers Please click here for an enlarged chart of NVIDIA Corp (NASDAQ:NVDA). 
Via Benzinga
Topics Economy
Nvidia's AI Reign: Fueling Market Gains and Forging a New Industrial Revolution
Nvidia (NASDAQ: NVDA) stands as the undisputed titan of the artificial intelligence (AI) era, its stock performance a primary catalyst for the recent, unprecedented surge in global financial markets.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
Via Investor Brand Network
Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug
Zepbound vials will be offered for pick-up at Walmart pharmacies nationwide by mid-November. 
Via Stocktwits
1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner
It offers compelling weight-loss drugs -- and a compelling stock price, too. 
Via The Motley Fool
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
This stock has caught fire after some recent events, but how long will that last? 
Via The Motley Fool
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.